Would you recommend iron supplements for someone with blood loss associated anaemia?

Iron Supplementation for Blood Loss-Associated Anemia

Direct Recommendation

Yes, oral iron tablets are strongly recommended as first-line treatment for blood loss-associated anemia, specifically ferrous sulfate 200 mg (65 mg elemental iron) once daily, which should be started immediately upon diagnosis. 1

---

Initial Treatment Protocol

Start oral ferrous sulfate 200 mg once daily immediately without delaying for diagnostic workup, as this is the preferred first-line treatment due to proven effectiveness and lowest cost. 1, 2

Optimizing Absorption

• Add vitamin C (ascorbic acid) 500 mg with each iron dose to enhance absorption, particularly critical when iron stores are severely depleted. 1, 3
• Take iron on an empty stomach for optimal absorption, though taking with food is acceptable if gastrointestinal side effects occur. 1
• Avoid tea and coffee within 1 hour of taking iron, as these inhibit absorption. 1

Dosing Strategy

• Once-daily dosing is superior to multiple daily doses because it improves tolerance while maintaining equal or better iron absorption due to hepcidin regulation. 1, 4
• If daily dosing causes intolerable side effects, alternate-day dosing (every other day) increases fractional iron absorption and improves tolerance with similar efficacy. 1, 4
• Never prescribe multiple doses per day—this increases side effects without improving efficacy due to hepcidin-mediated absorption blockade. 1

---

Expected Response and Monitoring

• Hemoglobin should rise by approximately 2 g/dL after 3-4 weeks of treatment. 1, 5
• Check hemoglobin at 4 weeks; failure to rise by 2 g/dL indicates poor compliance, continued blood loss, or malabsorption. 1
• Continue oral iron for 3 months after hemoglobin normalizes to fully replenish iron stores—total treatment typically lasts 6-7 months. 1, 2
• Monitor hemoglobin and red cell indices every 3 months for the first year, then again after another year. 1

---

When to Switch to Intravenous Iron

While oral iron is first-line, intravenous iron should replace oral therapy in specific circumstances:

Absolute Indications for IV Iron

• Intolerance to at least two different oral iron preparations (after trying ferrous sulfate, ferrous fumarate, and ferrous gluconate). 1, 3
• Active inflammatory bowel disease with hemoglobin <10 g/dL, as inflammation-induced hepcidin elevation severely impairs oral iron absorption. 1, 3
• Post-bariatric surgery patients due to disrupted duodenal absorption mechanisms. 1
• Ongoing gastrointestinal blood loss exceeding oral replacement capacity. 1

Relative Indications for IV Iron

• Celiac disease with inadequate response to oral iron despite strict gluten-free diet adherence. 1
• Failure of ferritin levels to improve after 4 weeks of compliant oral therapy. 1
• Need for rapid correction in severe, symptomatic anemia with circulatory compromise (though packed red cell transfusion may be needed first). 1

Preferred IV Iron Formulations

• Choose IV iron preparations that replace iron deficits in 1-2 infusions rather than multiple infusions to minimize risk. 1, 6
• Ferric carboxymaltose (500-1000 mg single doses delivered within 15 minutes) is a preferred formulation. 1, 5
• All IV iron formulations have similar overall safety profiles; true anaphylaxis is very rare (0.6-0.7%). 1

---

Alternative Oral Formulations

If ferrous sulfate is not tolerated:

• Ferrous fumarate or ferrous gluconate are equally effective alternatives, though typically more expensive. 1, 4
• No single oral iron formulation has any therapeutic advantage over another—the choice is purely economic. 1

---

Addressing the Underlying Cause

While starting iron supplementation immediately, simultaneously investigate the source of blood loss:

• In premenopausal women, assess menstrual blood loss first, as menorrhagia accounts for iron deficiency in 5-10% of menstruating women. 1
• In men and postmenopausal women, gastrointestinal evaluation with upper endoscopy and colonoscopy is recommended. 1, 2
• Screen for celiac disease with antiendomysial antibody and IgA measurement, as this is a common cause of malabsorption. 1

---

Critical Pitfalls to Avoid

• Do not prescribe multiple daily doses (e.g., three times daily)—this increases side effects without improving efficacy. 1, 4
• Do not stop iron therapy when hemoglobin normalizes—continue for 3 months to replenish stores. 1
• Do not overlook vitamin C supplementation when oral iron response is suboptimal. 1, 3
• Do not continue oral iron indefinitely without response—reassess after 4 weeks and switch to IV iron if hemoglobin fails to rise. 1
• Do not prescribe oral iron to patients with active inflammatory bowel disease and hemoglobin <10 g/dL—use IV iron instead. 1, 3

---

Special Considerations for Blood Loss Anemia

• If blood loss is ongoing and exceeds oral replacement capacity, IV iron is preferred. 1
• In cases of severe symptomatic anemia with hemodynamic instability, packed red cell transfusion followed by iron replacement (preferably IV) is appropriate. 1
• Treat the underlying cause of blood loss while supplementing iron—iron therapy alone is insufficient if bleeding continues. 1, 2

---

Failure to Respond

If anemia does not resolve within 6 months despite appropriate iron therapy:

• Reassess for ongoing blood loss. 1
• Evaluate for malabsorption syndromes. 1
• Consider further gastrointestinal investigation. 1
• Verify patient adherence to therapy. 1
• Consider hematology consultation for complex cases. 1